Skip to main content
Clinical Trials/NCT05718284
NCT05718284
Recruiting
Not Applicable

High Flow Nasal Cannula Oxygen Administration Versus Standard Care After Esophagectomy for Cancer: a Randomized Controlled Trial.

Cristian Deana1 site in 1 country320 target enrollmentApril 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Esophageal Cancer
Sponsor
Cristian Deana
Enrollment
320
Locations
1
Primary Endpoint
POST-OPERATIVE PULMONARY COMPLICATIONS
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This study will compare the effect of HFNC versus standard oxygen administration after elective esophagectomy for cancer.

Registry
clinicaltrials.gov
Start Date
April 1, 2023
End Date
January 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Cristian Deana
Responsible Party
Sponsor Investigator
Principal Investigator

Cristian Deana

MEDICAL doctor, Anesthesiologist and Critical Care Physician

Azienda Sanitaria-Universitaria Integrata di Udine

Eligibility Criteria

Inclusion Criteria

  • elective esophagectomy for cancer
  • AGE 18-85
  • Written informed consent

Exclusion Criteria

  • COPD≥ III stage according to GOLD criteria
  • FEV1\<50%
  • BMI\<17 or \>35 Kg/m2
  • CKD with eGFR\<60 mL/min

Outcomes

Primary Outcomes

POST-OPERATIVE PULMONARY COMPLICATIONS

Time Frame: within 30 days after surgery

Describe the frequency of PPC that include: pneumonia, pleural effusion, pneumothorax, atelectasis, ARDS, aspiration pneumonia, trachea-bronchial lesion, air leak

Secondary Outcomes

  • CARDIO-VASCULAR COMPLICATIONS(within 30 days after surgery)

Study Sites (1)

Loading locations...

Similar Trials